Cart
sales@molnova.com
Elbasvir
CAS No. 1370468-36-2
Elbasvir( MK-8742 )
Catalog No. M17980 CAS No. 1370468-36-2
Elbasvir is an inhibitor of nonstructural protein 5A (NS5A) of hepatitis C virus (HCV) being developed as a component of treatment regimens for chronic HCV infection.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 113 | In Stock |
|
| 2MG | 48 | In Stock |
|
| 5MG | 72 | In Stock |
|
| 10MG | 116 | In Stock |
|
| 25MG | 211 | In Stock |
|
| 50MG | 346 | In Stock |
|
| 100MG | 555 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameElbasvir
-
NoteResearch use only, not for human use.
-
Brief DescriptionElbasvir is an inhibitor of nonstructural protein 5A (NS5A) of hepatitis C virus (HCV) being developed as a component of treatment regimens for chronic HCV infection.
-
DescriptionElbasvir is an inhibitor of nonstructural protein 5A (NS5A) of hepatitis C virus (HCV) being developed as a component of treatment regimens for chronic HCV infection.
-
In Vitro——
-
In Vivo——
-
SynonymsMK-8742
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
RecptorHCV NS5A
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number1370468-36-2
-
Formula Weight882.02
-
Molecular FormulaC49H55N9O7
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 50 mg/mL 56.69 mM; H2O : < 0.1 mg/mL
-
SMILESCOC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C1N=CC(=N1)c1ccc2n3[C@@H](Oc4cc(ccc4-c3cc2c1)C1C=NC(=N1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lahser, F.C., et al. Antimicrob. Agents Chemother. 60(5), 2954-2964 (2016).
molnova catalog
related products
-
Mosapride Citrate
Mosapride Citrate is a gastroprokinetic agent that acts as a selective 5HT4 agonist.
-
Gamabufotalin
Gamabufotalin, a major bufadienolide of Chansu, has been used for treatment of COX-2-mediated diseases and cancer therapy due to its desirable metabolic stability and less adverse effect.
-
Pimethixene
Pimethixene is a highly potent 5-HT1A, 5-HT2A, 5-HT2B, 5-HT2C, histamine H1, dopamine D2 and D4.4 as well as muscarinic M1 and M2 receptors antagonist(pKis of 7.63, 10.22, 10.44, 8.42, 10.14, 8.19, 7.54, 8.61 and 9.38, respectively).
